SEC Form 4 · accession 0001123292-19-000030
PRECIGEN, INC. · PGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas D. Reed
Officer — Chief Science Officer
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 5:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356090
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 31, 2018 | S | 30,000 | $6.3557 | D | 72,715 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale undertaken by reporting person's lender to whom the shares were pledged.